Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
- 11 March 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (10), 757-763
- https://doi.org/10.1056/nejm199903113401003
Abstract
Drug-induced psychosis is a difficult problem to manage in patients with Parkinson's disease. Multiple open-label studies have reported that treatment with clozapine at low doses ameliorates psychosis without worsening parkinsonism.This publication has 51 references indexed in Scilit:
- Low Dose of Clozapine in the Treatment of Dopaminergic Psychosis in Parkinsonʼs DiseaseClinical Neuropharmacology, 1997
- The use of Clozapine in Parkinson's diseaseAustralian and New Zealand Journal of Medicine, 1994
- Acute intermittent porphyria and mental illness – a family studyActa Psychiatrica Scandinavica, 1994
- Levodopa Drug Holiday Versus Drug Dosage Reduction in Parkinsonʼs DiseaseClinical Neuropharmacology, 1994
- Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's diseaseActa Neurologica Scandinavica, 1988
- Idiopathic Parkinsonʼs Disease in a Chronic Schizophrenic PatientClinical Neuropharmacology, 1987
- Parkinson's Disease: Follow‐up After “Drug Holiday”The Journal of Clinical Pharmacology, 1986
- Sex differences in adolescent psychopathologyActa Psychiatrica Scandinavica, 1986
- Drug Holiday in the Management of Parkinson DiseaseClinical Neuropharmacology, 1982
- ParkinsonismNeurology, 1967